LBA57 Neoadjuvant nivolumab (N) + chemotherapy (C) in the phase III CheckMate 816 study: 3-y results by tumor PD-L1 expression

M. Provencio Pulla, Patrick M. Forde, J.D. Spicer, C. Wang, Shun Lu, Tetsuya Mitsudomi, Mark M. Awad, Enriqueta Felip, Stephen Broderick, Steven Swanson, Julie R. Brahmer, Keith M. Kerr, G. Saylors, Fumihiro Tanaka, K-N. Chen, Mia Tran, J.L. Cai, Javed Mahmood, S. Meadows–Shropshire, Nicolas Girard